100 related articles for article (PubMed ID: 7605862)
1. Spiramycin in triple therapy of Helicobacter pylori-associated peptic ulcer disease. An open pilot study with 12-month follow-up.
Berstad A; Berstad K; Wilhelmsen I; Hatlebakk JG; Nesje LB; Hausken T
Aliment Pharmacol Ther; 1995 Apr; 9(2):197-200. PubMed ID: 7605862
[TBL] [Abstract][Full Text] [Related]
2. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
[TBL] [Abstract][Full Text] [Related]
3. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection.
Berstad A; Hatlebakk JG; Wilhelmsen I; Berstad K; Bang CJ; Nysaeter G; Hausken T; Weberg R; Nesje LB; Hjartholm AS
Hepatogastroenterology; 1995; 42(5):655-9. PubMed ID: 8751230
[TBL] [Abstract][Full Text] [Related]
4. Bismuth therapy for Helicobacter pylori infection. A review of five years experience at a university hospital in Norway.
Berstad A; Olafsson S; Tefera S; Berstad K; Hundal O; Bergseth M; Wilhelmsen I
J Physiol Pharmacol; 1996 Mar; 47(1):31-49. PubMed ID: 8777305
[TBL] [Abstract][Full Text] [Related]
5. [10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year].
Berstad A; Berstad K; Hatlebakk JG; Wilhelmsen I; Nysaeter G; Bang CJ; Hausken T; Nesje LB; Hjartholm AS; Hundal O
Tidsskr Nor Laegeforen; 1994 Sep; 114(21):2477-9. PubMed ID: 7940447
[TBL] [Abstract][Full Text] [Related]
6. Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers.
Olafsson S; Hatlebakk JG; Berstad A
Scand J Gastroenterol; 2002 Dec; 37(12):1386-94. PubMed ID: 12523587
[TBL] [Abstract][Full Text] [Related]
7. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
[TBL] [Abstract][Full Text] [Related]
8. Spiramycin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazole.
Olafsson S; Berstad A; Bang CJ; Nysaeter G; Coll P; Tefera S; Hatlebakk JG; Hausken T; Olafsson T
Aliment Pharmacol Ther; 1999 May; 13(5):651-9. PubMed ID: 10233189
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
10. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
11. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.
Lerang F; Moum B; Ragnhildstveit E; Sandvei PK; Tolås P; Whist JE; Henriksen M; Haug JB; Berge T
Am J Gastroenterol; 1998 Feb; 93(2):212-6. PubMed ID: 9468244
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori: the results of a pilot study of 3, 5 & 7 day triple antibiotic regime with bismuth for one month.
O'Connor HJ; Cunnane K; Collins JS; Sloan JM; Johnston BT; Bamford KC; Gilvarry J; O'Morain CA
Ir J Med Sci; 1997; 166(1):32-4. PubMed ID: 9057430
[TBL] [Abstract][Full Text] [Related]
13. Eradication of helicobacter pylori among patients from a primary care practice.
Gomollón F; Gimeno L; Valdepérez J; Yus C; Marzo J; Pérez-Caballero MC
J Fam Pract; 1996 Dec; 43(6):551-5. PubMed ID: 8969702
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole].
Wilhelmsen I; Hundal O; Berstad K; Berstad A
Tidsskr Nor Laegeforen; 1992 Oct; 112(25):3197-9. PubMed ID: 1462293
[TBL] [Abstract][Full Text] [Related]
15. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients.
Seppälä K; Färkkilä M; Nuutinen H; Hakala K; Väänänen H; Rautelin H; Kosunen TU
Scand J Gastroenterol; 1992 Nov; 27(11):973-6. PubMed ID: 1455197
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease.
Wilhelmsen I; Weberg R; Berstad K; Hausken T; Hundal O; Berstad A
Hepatogastroenterology; 1994 Feb; 41(1):43-7. PubMed ID: 8175114
[TBL] [Abstract][Full Text] [Related]
18. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
